We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Concentra Group (CON - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Concentra Group is a member of our Medical group, which includes 916 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Concentra Group is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for CON's full-year earnings has moved 8.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, CON has returned 103.3% so far this year. At the same time, Medical stocks have gained an average of 5.3%. This means that Concentra Group is performing better than its sector in terms of year-to-date returns.
Centene (CNC - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 67%.
For Centene, the consensus EPS estimate for the current year has increased 6.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Concentra Group belongs to the Medical Services industry, which includes 70 individual stocks and currently sits at #148 in the Zacks Industry Rank. On average, this group has gained an average of 8.4% so far this year, meaning that CON is performing better in terms of year-to-date returns.
In contrast, Centene falls under the Medical - HMOs industry. Currently, this industry has 7 stocks and is ranked #22. Since the beginning of the year, the industry has moved +25.8%.
Investors with an interest in Medical stocks should continue to track Concentra Group and Centene. These stocks will be looking to continue their solid performance.
View the Zacks #1 Rank List
Image: Bigstock
Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Concentra Group (CON - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Concentra Group is a member of our Medical group, which includes 916 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Concentra Group is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for CON's full-year earnings has moved 8.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, CON has returned 103.3% so far this year. At the same time, Medical stocks have gained an average of 5.3%. This means that Concentra Group is performing better than its sector in terms of year-to-date returns.
Centene (CNC - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 67%.
For Centene, the consensus EPS estimate for the current year has increased 6.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Concentra Group belongs to the Medical Services industry, which includes 70 individual stocks and currently sits at #148 in the Zacks Industry Rank. On average, this group has gained an average of 8.4% so far this year, meaning that CON is performing better in terms of year-to-date returns.
In contrast, Centene falls under the Medical - HMOs industry. Currently, this industry has 7 stocks and is ranked #22. Since the beginning of the year, the industry has moved +25.8%.
Investors with an interest in Medical stocks should continue to track Concentra Group and Centene. These stocks will be looking to continue their solid performance.